Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals (MDGL) Surged Following the Strong Launch and Execution of New Drug [Yahoo! Finance]
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its price target raised by analysts at HC Wainwright from $568.00 to $620.00. They now have a "buy" rating on the stock.
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $600.00 to $650.00. They now have an "outperform" rating on the stock.